SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -12.1% | 1,672 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $231 | +6.9% | 1,674 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $216 | -99.9% | 1,666 | -0.6% | 0.00% | -57.1% |
| Q4 2020 | $286,000 | +18.7% | 1,676 | -2.3% | 0.01% | +16.7% |
| Q3 2020 | $241,000 | -12.4% | 1,716 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $275,000 | +24.4% | 1,716 | 0.0% | 0.01% | +33.3% |
| Q4 2019 | $221,000 | -15.3% | 1,716 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $261,000 | +25.5% | 1,716 | -1.7% | 0.01% | -11.1% |
| Q1 2019 | $208,000 | -26.2% | 1,746 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $282,000 | +22.1% | 1,746 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $231,000 | – | 1,746 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |